Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synapsin-1 is a neuronal phosphoprotein encoded by the *SYN1* gene that is primarily associated with the cytoplasmic surface of synaptic vesicles in axon terminals of neurons[1][3][4]. It is the predominant member of the synapsin protein family and exists as two isoforms, Synapsin Ia and Synapsin Ib. Synapsin-1 plays a critical role in regulating synaptogenesis, axonogenesis, and the coordinated release of neurotransmitters by controlling the recruitment, clustering, and trafficking of synaptic vesicles[1][3][4]. Its function is tightly regulated by both phosphorylation (notably by cAMP-dependent protein kinase, calcium/calmodulin-dependent protein kinase II, mitogen-activated protein kinase, and cyclin-dependent kinase) and S-palmitoylation, which together modulate its ability to interact with F-actin and other cytoskeletal elements, thereby influencing synaptic vesicle dynamics and neurotransmission[1][2]. Mutations in the *SYN1* gene are associated with various neuropsychiatric and neurodevelopmental disorders, such as epilepsy and X-linked syndromes, including Rett syndrome[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synapsin-1 (SYN1).